{"id":"https://openalex.org/W2314280557","doi":"https://doi.org/10.1089/cdd.1986.3.239","title":"The Influence of Route of Administration on the Hepatic Uptake of Methotrexate","display_name":"The Influence of Route of Administration on the Hepatic Uptake of Methotrexate","publication_year":1986,"publication_date":"1986-01-01","ids":{"openalex":"https://openalex.org/W2314280557","doi":"https://doi.org/10.1089/cdd.1986.3.239","mag":"2314280557","pmid":"https://pubmed.ncbi.nlm.nih.gov/3567844"},"language":"en","primary_location":{"id":"doi:10.1089/cdd.1986.3.239","doi":"https://doi.org/10.1089/cdd.1986.3.239","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cdd.1986.3.239","pdf_url":null,"source":{"id":"https://openalex.org/S2764779454","display_name":"Cancer Drug Delivery","issn_l":"0732-9482","issn":["0732-9482","2332-5011"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Drug Delivery","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024249524","display_name":"Frank M. Balis","orcid":"https://orcid.org/0000-0002-8117-6926","observed_orcids":["https://orcid.org/0000-0002-8117-6926"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"FRANK M. BALIS","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"ROBERT F. MURPHY","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ROBERT F. MURPHY","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036582350","display_name":"Cynthia Lester McCully","orcid":"https://orcid.org/0000-0002-1149-518X","observed_orcids":["https://orcid.org/0000-0002-1149-518X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"CYNTHIA M. LESTER","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109539569","display_name":"David G. Poplack","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"DAVID G. POPLACK","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.16746411,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"3","issue":"4","first_page":"239","last_page":"242"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.48240000009536743,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.48240000009536743,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.1371999979019165,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0697999969124794,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":1.0},{"id":"https://openalex.org/keywords/route-of-administration","display_name":"route of administration","score":0.9459999799728394},{"id":"https://openalex.org/keywords/intraperitoneal-administration","display_name":"intraperitoneal administration","score":0.8600000143051147},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":1.0},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.6869999766349792},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.7879999876022339},{"id":"https://openalex.org/keywords/portal-circulation","display_name":"portal circulation","score":0.6740000247955322},{"id":"https://openalex.org/keywords/rats","display_name":"rats","score":0.5400000214576721}],"concepts":[{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.9205211400985718},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6401115655899048},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6002972722053528},{"id":"https://openalex.org/C2776093070","wikidata":"https://www.wikidata.org/wiki/Q621636","display_name":"Route of administration","level":2,"score":0.5979832410812378},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5858244299888611},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.533283531665802},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5329638123512268},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.495449423789978},{"id":"https://openalex.org/C125287762","wikidata":"https://www.wikidata.org/wiki/Q1758948","display_name":"Absorption (acoustics)","level":2,"score":0.46483632922172546},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32365164160728455},{"id":"https://openalex.org/C24890656","wikidata":"https://www.wikidata.org/wiki/Q82811","display_name":"Acoustics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007274","descriptor_name":"Injections, Intraperitoneal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/cdd.1986.3.239","doi":"https://doi.org/10.1089/cdd.1986.3.239","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cdd.1986.3.239","pdf_url":null,"source":{"id":"https://openalex.org/S2764779454","display_name":"Cancer Drug Delivery","issn_l":"0732-9482","issn":["0732-9482","2332-5011"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Drug Delivery","raw_type":"journal-article"},{"id":"pmid:3567844","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3567844","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer drug delivery","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1516233473","https://openalex.org/W1860659045","https://openalex.org/W1971035689","https://openalex.org/W1974528604","https://openalex.org/W2068243694","https://openalex.org/W2107241699","https://openalex.org/W2173427809"],"related_works":["https://openalex.org/W1937198559","https://openalex.org/W2328550755","https://openalex.org/W3024831594","https://openalex.org/W2035177312","https://openalex.org/W1987095777","https://openalex.org/W2313836274","https://openalex.org/W2000127649","https://openalex.org/W1518060716","https://openalex.org/W2057568639","https://openalex.org/W2108109304"],"abstract_inverted_index":{"The":[0,78,129],"present":[1],"study":[2,133],"was":[3,88,100],"designed":[4],"to":[5,142,151],"determine":[6],"if":[7],"the":[8,20,37,56,60,73,111,148],"hepatic":[9,26,82],"toxicity":[10],"of":[11,32,42,51,69,131,145],"chronic":[12,49],"low-dose":[13],"methotrexate":[14,43,70,83,108,146],"could":[15],"be":[16],"circumvented":[17],"by":[18,54,72],"administering":[19],"drug":[21,27,67],"systemically,":[22],"avoiding":[23],"high":[24],"initial":[25],"exposure":[28],"resulting":[29],"from":[30],"absorption":[31],"an":[33],"oral":[34,137],"dose":[35],"into":[36],"portal":[38,61],"circulation.":[39],"Hepatic":[40],"concentrations":[41,109],"were":[44,76,114],"determined":[45],"in":[46,110,147],"rats":[47],"following":[48,85,96],"administration":[50,87,98,138],"1":[52],"mg/kg":[53],"either":[55],"intraperitoneal":[57,86],"(absorbed":[58],"via":[59],"circulation)":[62],"or":[63],"subcutaneous":[64,97],"route.":[65],"Plasma":[66],"profiles":[68],"administered":[71],"two":[74],"routes":[75],"similar.":[77],"mean":[79],"(+/-":[80],"S.D.)":[81],"concentration":[84],"3.12":[89],"+/-":[90,102,116,120],".47":[91],"nmol/gm":[92,122],"wet":[93,123],"weight":[94],"and":[95,118],"it":[99],"2.68":[101],".52":[103],"(p":[104,126],"=":[105,127],".06).":[106],"Renal":[107],"2":[112],"groups":[113],"1.23":[115],".27":[117],"1.26":[119],".49":[121],"weight,":[124],"respectively":[125],".88).":[128],"results":[130],"this":[132],"suggest":[134],"that":[135,136],"does":[139],"not":[140],"lead":[141],"greater":[143],"accumulation":[144],"liver":[149],"compared":[150],"systemic":[152],"administration.":[153]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}